As a consequence of its dual metabolic and antiapoptotic function, HK2 (over)expression is associated with unfavorable prognosis and radiotherapy/chemotherapy resistance in diverse tumor settings [8], whereas its silencing or genetic ablation abrogates neoplastic growth and restores sensitivity to antitumor treatments [11]. This evidence concerns the gene HK2 and neoplasm.